Results 191 to 200 of about 36,198 (299)

Osteopontin in HFpEF

open access: yesJournal of the American College of Cardiology, 2019
Fadi N. Salloum, Vinh Q. Chau
openaire   +1 more source

Diastolic Dysfunction in Acute and Critical Illness: Acute Pathophysiology to Chronic Heart Failure. [PDF]

open access: yesJACC Adv
Fisher T   +10 more
europepmc   +1 more source

Molecular Signature of HFpEF

open access: yesJACC: Basic to Translational Science, 2021
Andrew A. Gibb   +10 more
openaire   +1 more source

Risk factors for persistent decline in eGFR of Japanese patients with diabetes: Analysis using a large‐scale diabetes registry J‐DREAMS

open access: yesJournal of Diabetes Investigation, Volume 17, Issue 2, Page 242-255, February 2026.
ABSTRACT Aims/Introduction This study aimed to identify clinical predictors associated with sustained decline in estimated glomerular filtration rate (eGFR) among Japanese individuals diagnosed with diabetes mellitus. Materials and Methods We conducted a retrospective analysis using J‐DREAMS (Japan Diabetes compREhensive database project based on an ...
Kota Yamada   +5 more
wiley   +1 more source

Diagnosing HFpEF

open access: yesJACC: Cardiovascular Imaging, 2018
openaire   +1 more source

Effects of soluble guanylyl cyclase stimulation on muscle oxygenation and exercise capacity in heart failure with mildly reduced ejection fraction

open access: yesExperimental Physiology, Volume 111, Issue 2, Page 474-488, 1 February 2026.
Abstract Heart failure (HF) with a mildly reduced ejection fraction (HFmrEF; 40%–49%) is present in ≤25% of HF patients. Therapeutic treatment options for HFmrEF‐associated exercise intolerance are limited. Nitric oxide (NO)‐independent stimulation of soluble guanylyl cyclase to improve peripheral vasodilatation offers a novel approach to enhance ...
Ramona E. Weber   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy